Abstract
Serological laboratory diagnosis of infectious diseases is inflicted with several kinds of basic problems. One difficulty relates to the fact that the serological diagnosis of infectious diseases is double indirect: The first indirect aim in diagnosing an infectious disease is to identify the microbial agent that caused the disease. The second indirect aim is to identify this infectious agent by measuring the patient’s immune response to the potential agent. Thus, the serological test is neither measuring directly disease nor the cause of the disease, but the patient’s immune system. The latter poses another type of problem, because each person’s immune system is unique. The immune response to an infectious agent is usually of polyclonal nature, and the exact physicochemical properties of antibodies are unique for each clone of antibody. The clonal makeup and composition and, therefore, the way an individual’s immune system sees an infectious agent, depends not only on the genetic background of the person but also on the individual experience from former encounters with various infectious agents. In consequence, the reaction of a patient’s serum in an analytical system is not precisely predictable. Also, the antigenic makeup of an infectious agent is not always foreseeable. Antigenic variations leading to different serotypes is a quite common phenomenon. Altogether, these biological problems lead to complexities in selecting the appropriate tests and strategies for testing, in interpreting the results, and in standardizing serological test systems. For that reason, a close collaboration of the laboratory with the clinic is mandatory to avoid erroneous conclusions from serological test results, which might lead to wrong decisions in patient care.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
NCCLS (2001) Specifications for Immunological Testing for Infectious Diseases; Approved Guideline-Second Edition, in NCCLS Document I/LA18-A2 (NCCLS, ed.), NCCLS, Wayne, PA, pp. 1–46.
Tosteson, A. N. A., Weinstein, M. C., Wittenberg, J., and Begg, C. B. (1994) ROC curve regression analysis: the use of ordinal regression models for diagnostic test assessment. Environ. Health Perspect. 102, 73–78.
Sorribas, A., March, J., and Trujillano, J. (2002) A new parametric method based on S-distributions for computing receiver operating characteristic curves for continuous diagnostic tests. Stat. Med 21, 1213–1235.
Dujardin, B., Vandenende, J., Vangompel, A., Unger, J. P., and Vanderstuyft, P. (1994) Likelihood ratios—a real improvement for clinical decision making. Eur. J. Epidemiol. 10, 29–36.
Biggerstaff, B. J. (2000) Comparing diagnostic tests: a simple graphic using likelihood ratios. Stat. Med 19, 649–663.
Choi, B. C. (1998) Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test. Am. J. Epidemiol. 148, 1127–1132.
Choi, B. C. (1997) Causal modeling to estimate sensitivity and specificity of a test when prevalence changes. Epidemiology 8, 80–86.
Brenner, H. and Gefeller, O. (1997) Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Stat. Med 16, 981–991.
Vanderschouw, Y. T., Vandijk, R., and Verbeek, A. L. M. (1995) Problems in selecting the adequate patient population from existing data files for assessment studies of new diagnostic tests. J. Clin. Epidemiol. 48, 417–422.
Broder, C. C., Earl, P. L., Long, D., Abedon, S. T., Moss, B., and Doms, R. W. (1994) Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and-sensitive monoclonal antibodies. Proc. Natl. Acad. Sci. USA 91, 11,699–11,703.
Dyson, H. J. and Wright, P. E. (1995) Antigenic peptides. FASEB J. 9, 37–42.
Gurunath, R., Beena, T. K., Adiga, P. R., and Balaram, P. (1995) Enhancing peptide antigenicity by helix stabilization. FEBS Lett. 361, 176–178.
Union, A., Meheus, L., Humbel, R. L., et al. (2002) Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay. Arthritis Rheum. 46, 1185–1195.
Borza, D. B., Bondar, O., Todd, P., et al. (2002) Quaternary Organization of the Goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intraprotomer interactions with the alpha 4 and alpha 5 NC1 domains. J. Biol. Chem. 277, 40,075–40,083.
Mukherjee, J., Nussbaum, G., Scharff, M. D., and Casadevall, A. (1995) Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181, 405–409.
Prentice, L., Kiso, Y., Fukuma, N., et al. (1995) Monoclonal thyroglobulin autoantibodies: Variable region analysis and epitope recognition. J. Clin. Endocrinol. Metab. 80, 977–986.
Lovrich, S. D., Callister, S. M., Lim, L. C. L., Duchateau, B. K., and Schell, R. F. (1994) Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J. Infect. Dis. 170, 115–121.
Roost, H. P., Bachmann, M. F., Haag, A., et al. (1995) Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc. Natl. Acad. Sci. USA 92, 1257–1261.
Foote, J. and Eisen, H. N. (1995) Kinetic and affinity limits on antibodies produced during immune responses. Proc. Natl. Acad. Sci. USA 92, 1254–1256.
Braden, B. C. and Poljak, R. J. (1995) Structural features of the reactions: between antibodies and protein antigens. FASEB J. 9, 9–16.
Yuan, R. R., Casadevall, A., Spira, G., and Scharff, M. D. (1995) Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol. 154, 1810–1816.
Rademacher, T. W., Williams, P., and Dwek, R. A. (1994) Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc. Natl. Acad. Sci. USA 91, 6123–6127.
Lund, J., Takahashi, N., Pound, J. D., Goodall, M., Nakagawa, H., and Jefferis, R. (1995) Oligosaccharide protein interactions in IgG can modulate recognition by Fc gamma receptors. FASEB J. 9, 115–119.
Amzel, L. M. and Gaffney, B. J. (1995) Structural immunology: problems in molecular recognition. FASEB J. 9, 7–8.
Guddat, L. W., Shan, L., Fan, Z. C., et al. (1995) Intramolecular signaling upon complexation. FASEB J. 9, 101–106.
Soderlund, M., Brown, C. S., Spaan, W. J., Hedman, L., and Hedman, K. (1995) Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J. Infect. Dis. 172, 1431–1436.
Manaresi, E., Gallinella, G., Zerbini, M., Venturoli, S., Gentilomi, G., and Musiani, M. (1999) IgG immune response to B19 parvovirus VP1 and VP2 linear epitopes by immunoblot assay. J. Med. Virol. 57, 174–178.
Gray, J. J., Wreghitt, T. G., Mckee, T. A., et al. (1995) Internal quality assurance in a clinical virology laboratory. 1. Internal quality assessment. J. Clin. Pathol. 48, 168–173.
Gray, J. J., Wreghitt, T. G., Mckee, T. A., et al. (1995) Internal quality assurance in a clinical virology laboratory. 2. Internal quality control. J. Clin. Pathol. 48, 198–202.
Mugan, K., Carlson, I. H., and Westgard, J. O. (1994) Planning QC procedures for immunoassays. J. Clin. Immunoassay 17, 216–222.
Dimech, W., Bettoli, A., Eckert, D., et al. (1992) Multicenter evaluation of five commercial rubella virus immunoglobulin G kits which report in international units per milliliter. J. Clin. Microbiol. 30, 633–641.
Place, J. F., Truchaud, A., Ozawa, K., Pardue, H., and Schnipelsky, P. (1994) Use of artificial intelligence in analytical systems for the clinical laboratory. Clin. Chim. Acta 231, S5–S34.
Place, J. F., Truchaud, A., Ozawa, K., Pardue, H., and Schnipelsky, P. (1994) Use of artificial intelligence in analytical systems for the clinical laboratory. Ann. Biol. Clin. Paris 52, 729–743.
Winkel, P. (1994) Artificial intelligence within the chemical laboratory. Ann. Biol. Clin. Paris 52, 277–282.
Winkel, P. (1994) Multivariate analysis and expert systems. Scand. J. Clin. Lab. Invest. 54, 12–24.
Sharpe, P. K. and Caleb, P. (1994) Artificial neural networks within medical decision support systems. Scand. J. Clin. Lab. Invest. 54, 3–11.
Fierz, W. (2002) Information management driven by diagnostic patient data: right information for the right patient. Expert. Rev. Mol. Diagn. 2, 355–360.
Malakoff, D. (1999) Bayes offers a ‘new’ way to make sense of numbers [news] [see comments]. Science 286, 1460–1464.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Fierz, W. (2004). Basic Problems of Serological Laboratory Diagnosis. In: Decler, J., Reischl, U. (eds) Molecular Diagnosis of Infectious Diseases. Methods in Molecular Medicine™, vol 94. Humana Press. https://doi.org/10.1385/1-59259-679-7:393
Download citation
DOI: https://doi.org/10.1385/1-59259-679-7:393
Publisher Name: Humana Press
Print ISBN: 978-1-58829-221-6
Online ISBN: 978-1-59259-679-9
eBook Packages: Springer Protocols